Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
The Paralegal Certificate Program is designed and taught by local, practicing attorneys to prepare participants to be knowledgeable, ethical, and effective while emphasizing legal areas where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results